Raymond James: 'we continue to think that ALHC will continue to reap the gains from its durable and scalable business model'

March 2, 2026 11:58 AM EST Send to a Friend
Raymond James analyst John Ransom reiterated a Strong Buy rating and $27.00 price target on Alignment Healthcare Inc (NASDAQ: ALHC).The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login